Integrated Filing — IndAS

General information about company
Scrip Code	533121
NSE Symbol	EXPLEOSOL
MSEI Symbol	NOTLISTED
ISIN	INE201K01015
Name of company	Expleo Solutions Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	22-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	15-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Software Validation and Verification Services, Software Development and Engineering consultancy services
Start date and time of board meeting	22-May-2025   14:00:00
End date and time of board meeting	22-May-2025   18:00:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-02-06
Indicate Company website link for updated RPT policy of the Company	https://investors.expleo.com/corporate-governance/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable.

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	2557960000	10247960000
	Other income	29630000	103440000
	Total income	2587590000	10351400000
2	Expenses
(a)	Cost of materials consumed	17150000	74800000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	1384610000	5273330000
(e)	Finance costs	9410000	33220000
(f)	Depreciation, depletion and amortisation expense	78600000	386340000
(f)	Other Expenses
1	Impairment of goodwill	0	19000000
2	Other Expenses	796950000	3381660000
	Total other expenses	796950000	3400660000
	Total expenses	2286720000	9168350000
3	Total profit before exceptional items and tax	300870000	1183050000
4	Exceptional items	95710000	95710000
5	Total profit before tax	396580000	1278760000
6	Tax expense
7	Current tax	135530000	411580000
8	Deferred tax	-27760000	-86260000
9	Total tax expenses	107770000	325320000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	288810000	953440000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	288810000	953440000
17	Other comprehensive income net of taxes	-4860000	-5970000
18	Total Comprehensive Income for the period	283950000	947470000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	155200000	155200000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		5466190000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	18.61	61.43
	Diluted earnings (loss) per share from continuing operations	18.61	61.43
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	18.61	61.43
	Diluted earnings (loss) per share from continuing and discontinued operations	18.61	61.43
24	Debt equity ratio	0	0
25	Debt service coverage ratio	0	0
26	Interest service coverage ratio	0	0
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	1005600000
	Capital work-in-progress	0
	Investment property	0
	Goodwill	0
	Other intangible assets	112750000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	34820000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	62240000
	Total non-current financial assets	97060000
	Deferred tax assets (net)	123520000
	Other non-current assets	210370000
	Total non-current assets	1549300000
2	Current assets
	Inventories	0
	Current financial asset
	Current investments	0
	Trade receivables, current	2622780000
	Cash and cash equivalents	1934570000
	Bank balance other than cash and cash equivalents	118720000
	Loans, current	0
	Other current financial assets	572950000
	Total current financial assets	5249020000
	Current tax assets (net)	0
	Other current assets	440290000
	Total current assets	5689310000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	7238610000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	155200000
	Other equity	5466190000
	Total equity attributable to owners of parent	5621390000
	Non controlling interest
	Total equity	5621390000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	368700000
	Total non-current financial liabilities	368700000
	Provisions, non-current	126550000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	495250000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	1620000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	377090000
	Total Trade payable	378710000
	Other current financial liabilities	350710000
	Total current financial liabilities	729420000
	Other current liabilities	185380000
	Provisions, current	117080000
	Current tax liabilities (Net)	90090000
	Deferred government grants, Current	0
	Total current liabilities	1121970000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	1617220000
	Total equity and liabilites	7238610000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified to profit or loss	-6490000	-7980000
	Total Amount of items that will not be reclassified to profit and loss	-6490000	-7980000
2	Income tax relating to items that will not be reclassified to profit or loss	-1630000	-2010000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-4860000	-5970000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1278760000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			33220000
	Adjustments for decrease (increase) in inventories			0
	Adjustments for decrease (increase) in trade receivables, current			193660000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			102300000
	Adjustments for decrease (increase) in other non-current assets			-61650000
	Adjustments for other financial assets, non-current			-20030000
	Adjustments for other financial assets, current			-222520000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			40810000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			82720000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			386340000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			19000000
	Adjustments for provisions, current			69230000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			-127890000
	Adjustments for other financial liabilities, non-current			-40350000
	Adjustments for unrealised foreign exchange losses gains			79870000
	Adjustments for dividend income			0
	Adjustments for interest income			34750000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-26970000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-5300000
	Other adjustments to reconcile profit (loss)			-95710000
	Other adjustments for non-cash items			82120000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			454100000
	Net cash flows from (used in) operations			1732860000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			378840000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			1354020000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			-104410000
	Proceeds from sales of property, plant and equipment			710000
	Purchase of property, plant and equipment			76580000
	Proceeds from sales of investment property			0
	Purchase of investment property			-176980000
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			29910000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-44480000
	Net cash flows from (used in) investing activities	190950000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			0
	Payments of lease liabilities			61940000
	Dividends paid			775990000
	Interest paid			33040000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-870970000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			674000000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			14510000
	Net increase (decrease) in cash and cash equivalents			688510000
	Cash and cash equivalents cash flow statement at beginning of period			1246060000
	Cash and cash equivalents cash flow statement at end of period			1934570000